A detailed history of Bank Of Montreal transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 14,576 shares of TXG stock, worth $213,829. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,576
Holding current value
$213,829
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$15.71 - $23.49 $228,988 - $342,390
14,576 New
14,576 $329,000
Q1 2024

May 13, 2024

SELL
$36.08 - $54.3 $14.4 Million - $21.7 Million
-399,717 Reduced 98.61%
5,628 $211,000
Q4 2023

Feb 08, 2024

BUY
$34.32 - $57.55 $13.7 Million - $22.9 Million
398,760 Added 6055.58%
405,345 $22.7 Million
Q3 2023

Nov 01, 2023

SELL
$40.86 - $62.98 $8.77 Million - $13.5 Million
-214,666 Reduced 97.02%
6,585 $271,000
Q2 2023

Aug 02, 2023

BUY
$50.96 - $58.72 $10.2 Million - $11.7 Million
199,328 Added 909.22%
221,251 $12.4 Million
Q1 2023

Jun 13, 2024

BUY
$35.33 - $55.79 $42,325 - $66,836
1,198 Added 21.29%
6,826 $380,000
Q4 2022

Feb 01, 2023

SELL
$24.4 - $41.3 $11,468 - $19,411
-470 Reduced 2.1%
21,923 $798,000
Q3 2022

Nov 10, 2022

BUY
$28.48 - $52.59 $497,545 - $918,747
17,470 Added 354.86%
22,393 $804,000
Q2 2022

Aug 11, 2022

BUY
$36.95 - $82.41 $38,169 - $85,129
1,033 Added 26.56%
4,923 $242,000
Q1 2022

May 12, 2022

SELL
$55.7 - $145.79 $1.66 Million - $4.34 Million
-29,747 Reduced 88.44%
3,890 $293,000
Q4 2021

Feb 11, 2022

SELL
$135.05 - $182.59 $782,749 - $1.06 Million
-5,796 Reduced 14.7%
33,637 $5.08 Million
Q3 2021

Nov 12, 2021

BUY
$145.58 - $192.14 $232,054 - $306,271
1,594 Added 4.21%
39,433 $5.78 Million
Q2 2021

Aug 12, 2021

BUY
$134.22 - $202.37 $5.08 Million - $7.66 Million
37,839 New
37,839 $7.63 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.39B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.